BGI Group has won the latest round in its battle with Illumina over DNA sequencing patents.
And it won big.
Partner David Bilsker led a trial team to a $333 million verdict for infringement of two patents owned by BGI Group, while also invalidating two patents asserted by competitor Illumina.
May 09, 2022 at 01:29 PM
3 minute read
The original version of this story was published on Delaware Business Court Insider
BGI Group has won the latest round in its battle with Illumina over DNA sequencing patents.
And it won big.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS